
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2
Olha Puhach, Kenneth Adea, Nicolas Hulo, et al.
Nature Medicine (2022) Vol. 28, Iss. 7, pp. 1491-1500
Open Access | Times Cited: 323
Olha Puhach, Kenneth Adea, Nicolas Hulo, et al.
Nature Medicine (2022) Vol. 28, Iss. 7, pp. 1491-1500
Open Access | Times Cited: 323
Showing 26-50 of 323 citing articles:
Infectious viral shedding of SARS-CoV-2 Delta following vaccination: A longitudinal cohort study
Miguel Garcia-Knight, Khamal Anglin, Michel Tassetto, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 9, pp. e1010802-e1010802
Open Access | Times Cited: 46
Miguel Garcia-Knight, Khamal Anglin, Michel Tassetto, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 9, pp. e1010802-e1010802
Open Access | Times Cited: 46
Viral load dynamics of SARS-CoV-2 Delta and Omicron variants following multiple vaccine doses and previous infection
Yonatan Woodbridge, Sharon Amit, Amit Huppert, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 46
Yonatan Woodbridge, Sharon Amit, Amit Huppert, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 46
COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA.1 Periods
Carina Marquez, Andrew D. Kerkhoff, John Schrom, et al.
JAMA Network Open (2022) Vol. 5, Iss. 10, pp. e2235844-e2235844
Open Access | Times Cited: 41
Carina Marquez, Andrew D. Kerkhoff, John Schrom, et al.
JAMA Network Open (2022) Vol. 5, Iss. 10, pp. e2235844-e2235844
Open Access | Times Cited: 41
SARS-CoV-2 Omicron BA.1 and BA.2 are attenuated in rhesus macaques as compared to Delta
Neeltje van Doremalen, Manmeet Singh, Taylor A. Saturday, et al.
Science Advances (2022) Vol. 8, Iss. 46
Open Access | Times Cited: 41
Neeltje van Doremalen, Manmeet Singh, Taylor A. Saturday, et al.
Science Advances (2022) Vol. 8, Iss. 46
Open Access | Times Cited: 41
Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences
Reem Hoteit, Hadi M. Yassine
Vaccines (2022) Vol. 10, Iss. 6, pp. 919-919
Open Access | Times Cited: 38
Reem Hoteit, Hadi M. Yassine
Vaccines (2022) Vol. 10, Iss. 6, pp. 919-919
Open Access | Times Cited: 38
Variability in the Clinical Course of COVID-19 in a Retrospective Analysis of a Large Real-World Database
Robert Flisiak, Piotr Rzymski, Dorota Zarębska‐Michaluk, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 149-149
Open Access | Times Cited: 38
Robert Flisiak, Piotr Rzymski, Dorota Zarębska‐Michaluk, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 149-149
Open Access | Times Cited: 38
Reconsideration of Antinucleocapsid IgG Antibody as a Marker of SARS-CoV-2 Infection Postvaccination for Mild COVID-19 Patients
Santosh Dhakal, Tong Yu, Anna Yin, et al.
Open Forum Infectious Diseases (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 37
Santosh Dhakal, Tong Yu, Anna Yin, et al.
Open Forum Infectious Diseases (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 37
Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022
Toon Braeye, Lucy Catteau, Ruben Brondeel, et al.
Vaccine (2023) Vol. 41, Iss. 20, pp. 3292-3300
Open Access | Times Cited: 37
Toon Braeye, Lucy Catteau, Ruben Brondeel, et al.
Vaccine (2023) Vol. 41, Iss. 20, pp. 3292-3300
Open Access | Times Cited: 37
SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in human airway and intestinal organoid models
Anna Z. Mykytyn, Tim I. Breugem, Maarten H. Geurts, et al.
Journal of Virology (2023) Vol. 97, Iss. 8
Open Access | Times Cited: 27
Anna Z. Mykytyn, Tim I. Breugem, Maarten H. Geurts, et al.
Journal of Virology (2023) Vol. 97, Iss. 8
Open Access | Times Cited: 27
Effect of SARS-CoV-2 prior infection and mRNA vaccination on contagiousness and susceptibility to infection
Denis Mongin, Nils Bürgisser, Gustavo Laurie, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Denis Mongin, Nils Bürgisser, Gustavo Laurie, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial
Júlia Corominas, Carme Garriga, Antoni Prenafeta, et al.
The Lancet Regional Health - Europe (2023) Vol. 28, pp. 100613-100613
Open Access | Times Cited: 24
Júlia Corominas, Carme Garriga, Antoni Prenafeta, et al.
The Lancet Regional Health - Europe (2023) Vol. 28, pp. 100613-100613
Open Access | Times Cited: 24
Viral kinetics of SARS-CoV-2 following onset of COVID-19 in symptomatic patients infected with the ancestral strain and omicron BA.2 in Hong Kong: a retrospective observational study
Yun Lin, Peng Wu, Tim K. Tsang, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 9, pp. e722-e731
Closed Access | Times Cited: 21
Yun Lin, Peng Wu, Tim K. Tsang, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 9, pp. e722-e731
Closed Access | Times Cited: 21
Heterogeneous SARS-CoV-2 kinetics due to variable timing and intensity of immune responses
Katherine Owens, Shadisadat Esmaeili, Joshua T. Schiffer
JCI Insight (2024) Vol. 9, Iss. 9
Open Access | Times Cited: 11
Katherine Owens, Shadisadat Esmaeili, Joshua T. Schiffer
JCI Insight (2024) Vol. 9, Iss. 9
Open Access | Times Cited: 11
Combined analyses of within-host SARS-CoV-2 viral kinetics and information on past exposures to the virus in a human cohort identifies intrinsic differences of Omicron and Delta variants
Timothy Russell, Hermaleigh Townsley, Sam Abbott, et al.
PLoS Biology (2024) Vol. 22, Iss. 1, pp. e3002463-e3002463
Open Access | Times Cited: 8
Timothy Russell, Hermaleigh Townsley, Sam Abbott, et al.
PLoS Biology (2024) Vol. 22, Iss. 1, pp. e3002463-e3002463
Open Access | Times Cited: 8
Exploring the Complexities of Long COVID
Jackson Donald, Shymaa E. Bilasy, Catherine Yang, et al.
Viruses (2024) Vol. 16, Iss. 7, pp. 1060-1060
Open Access | Times Cited: 8
Jackson Donald, Shymaa E. Bilasy, Catherine Yang, et al.
Viruses (2024) Vol. 16, Iss. 7, pp. 1060-1060
Open Access | Times Cited: 8
Exhaled Breath Aerosol Shedding of Highly Transmissible Versus Prior Severe Acute Respiratory Syndrome Coronavirus 2 Variants
Jianyu Lai, Kristen K. Coleman, Sheldon Tai, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 5, pp. 786-794
Open Access | Times Cited: 35
Jianyu Lai, Kristen K. Coleman, Sheldon Tai, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 5, pp. 786-794
Open Access | Times Cited: 35
Biofunctionalization of Graphene‐Based FET Sensors through Heterobifunctional Nanoscaffolds: Technology Validation toward Rapid COVID‐19 Diagnostics and Monitoring
Esteban Piccinini, Gonzalo E. Fenoy, Agustín L. Cantillo, et al.
Advanced Materials Interfaces (2022) Vol. 9, Iss. 15
Open Access | Times Cited: 34
Esteban Piccinini, Gonzalo E. Fenoy, Agustín L. Cantillo, et al.
Advanced Materials Interfaces (2022) Vol. 9, Iss. 15
Open Access | Times Cited: 34
SARS-CoV-2—The Role of Natural Immunity: A Narrative Review
Sara Diani, Erika Leonardi, Attilio Cavezzi, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6272-6272
Open Access | Times Cited: 33
Sara Diani, Erika Leonardi, Attilio Cavezzi, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6272-6272
Open Access | Times Cited: 33
Resistance of Omicron subvariants BA.2.75.2, BA.4.6 and BQ.1.1 to neutralizing antibodies
Delphine Planas, Timothée Bruel, Isabelle Staropoli, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 31
Delphine Planas, Timothée Bruel, Isabelle Staropoli, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 31
Prevalence of Post-Coronavirus Disease Condition 12 Weeks After Omicron Infection Compared With Negative Controls and Association With Vaccination Status
Mayssam Nehme, Pauline Vetter, François Chappuis, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 9, pp. 1567-1575
Open Access | Times Cited: 31
Mayssam Nehme, Pauline Vetter, François Chappuis, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 9, pp. 1567-1575
Open Access | Times Cited: 31
Humoral and Cellular Immune Responses of COVID-19 vaccines against SARS-Cov-2 Omicron variant: a systemic review
Zhonghao Chen, Ying Zhang, Meng Wang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 12, pp. 4629-4641
Open Access | Times Cited: 30
Zhonghao Chen, Ying Zhang, Meng Wang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 12, pp. 4629-4641
Open Access | Times Cited: 30
SARS-CoV-2 viral load is associated with risk of transmission to household and community contacts
Darlene Bhavnani, Emily R. James, Kaitlyn E. Johnson, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 30
Darlene Bhavnani, Emily R. James, Kaitlyn E. Johnson, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 30
Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers
Gregory Joseph, John Barnes, Eduardo Azziz‐Baumgartner, et al.
JAMA (2022) Vol. 328, Iss. 15, pp. 1523-1523
Open Access | Times Cited: 30
Gregory Joseph, John Barnes, Eduardo Azziz‐Baumgartner, et al.
JAMA (2022) Vol. 328, Iss. 15, pp. 1523-1523
Open Access | Times Cited: 30
Early Introduction and Rise of the Omicron Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant in Highly Vaccinated University Populations
Brittany A. Petros, Jacquelyn Turcinovic, Nicole L. Welch, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e400-e408
Open Access | Times Cited: 28
Brittany A. Petros, Jacquelyn Turcinovic, Nicole L. Welch, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e400-e408
Open Access | Times Cited: 28
The wave of the SARS-CoV-2 Omicron variant resulted in a rapid spike and decline as highlighted by municipal wastewater surveillance
Francesca Cutrupi, Maria Cadonna, Serena Manara, et al.
Environmental Technology & Innovation (2022) Vol. 28, pp. 102667-102667
Open Access | Times Cited: 27
Francesca Cutrupi, Maria Cadonna, Serena Manara, et al.
Environmental Technology & Innovation (2022) Vol. 28, pp. 102667-102667
Open Access | Times Cited: 27